A-198 ESG Opportunities Harnessed During Pathology Transformation
Authors: Ellison T , Hughes L , Booth R , Walsh G , Cane P 
Published: October 2024

Abstract

Background
Synnovis (a SYNLAB business) is in the process of delivering one of the largest Pathology transformation programmes in the UK, moving to a seven-site hub and spoke model from 89 laboratories over a dispersed geography. This remit also presented an opportunity for SYNLAB to deliver on its Environmental Social Governance (ESG) ambitions, by embedding ESG principles into programme delivery. There are several examples within each ESG pillar that demonstrate the benefits to be leveraged during transformation.

Methods
SYNLAB’s vision is to deliver sustainable diagnostic services. The integration of ESG into both the decision-making process and transformation structure ties these ambitions into programme benefits realisation. As well as setting performance level targets, the delivery of ESG benefits provide measures of success throughout the transformation journey, motivating stakeholders and building confidence along the way.

Results
Environment:
The efficient use of space and LEAN principle design has consolidated the fragmented laboratory services spanning 15,000m2 into a bespoke, cutting-edge Pathology Hub with 6 spokes (hospital based services). The new hub building was designed to achieve BREEAM Excellent standards which measure performance against criteria such as energy management and efficiency, sustainable design and materials. The hub’s energy is from renewable-backed sources, and we will achieve a 47% reduction in CO2 equivalent (CO2e) emissions by unifying a significant proportion of its legacy footprint in this way. Further energy savings will be achieved through the associated analytical equipment consolidation, including a decrease from 50 to 14 microtomes, a decrease of 29 to 15 ventilated benches and a reduction of over 200 fridges and freezers across the service. In addition, substantial CO2e emissions savings are also being delivered by moving to a greener logistics provider, utilising electric vehicles and bikes. 2023 saw such emissions fall by 60% across Synnovis, helping to keep London’s air cleaner.
Social:
The transformation programme enables the hand back of over 6,000m2 of real estate to Synnovis’ NHS partners to use for critical hospital services (the equivalent of over 150 operating theatres).

Governance
Both internally and externally, ESG is integrated within the Synnovis organisational culture. For example, internally it applies mandatory sustainability metrics to its solution selection processes. These influenced the selection of Abbott’s Indexor solution to support the transformation of Blood Sciences, delivering a saving of over 2.8 million plastic sample bags every year. Externally, SYNLAB works with its partners to manage this substantial and complex transformation programme. Risk management is assured through transparency, securing confidence in the good use of public funds, ensuring responsiveness to customer and partner feedback, and ensuring accountability for and the delivery of targeted healthcare outcomes.

Conclusions
The integration of SYNLAB’s ESG strategy within the transformation programme is delivering tangible benefits across all ESG pillars. It has highlighted that in addition to the core outcome of services transformation, there are many more opportunities that can be realised as a result of making ESG an integral part of the pathology transformation programme.